Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome-Reference-Cited by-同舟云学术

Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome

Published:2019-01 Issue:1 Volume:25 Page:63-72
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Park Sung-Soo^ORCID,Jeon Young-Woo^ORCID,Min Gi June^ORCID,Park Silvia,Yahng Seung-Ah,Yoon Jae-Ho^ORCID,Shin Seung-Hwan,Lee Sung-Eun^ORCID,Cho Byung-Sik,Eom Ki-Seong,Lee Seok,Kim Hee-Je,Min Chang-Ki,Cho Seok-Goo^ORCID,Lee Jong Wook,Kim Yoo-Jin^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference49 articles.

1. Myelodysplastic syndromes;Ades;Lancet,2014

2. The lower risk MDS patient at risk of rapid progression;Mittelman;Leuk Res,2010

3. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation;Yoshizato;Blood,2017

4. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel;de Witte;Blood,2017

5. Reduced mortality after allogeneic hematopoietic-cell transplantation;Gooley;N Engl J Med,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased donor inhibitory KIR are associated with reduced GVHD and improved survival following HLA‐matched unrelated donor HCT in paediatric acute leukaemia;British Journal of Haematology;2024-03-05

2. Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation;Bone Marrow Transplantation;2024-02-06

3. Increased Donor Inhibitory KIR Are Associated with Reduced GVHD and Improved Survival Following HLA Matched Unrelated Donor HCT in Pediatric Acute Leukemia;2023-12-15

4. Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled Trial;Transplantation and Cellular Therapy;2023-06

5. Systematic review and meta-analysis of anti-thymocyte globulin dosage as a component of graft-versus-host disease prophylaxis;PLOS ONE;2023-04-18